Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

Market Cap	2.63B -40.7%
Revenue (ttm)	118.10M -26.0%
Net Income	-43.79M
EPS	-0.25
Shares Out	174.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,095,262
Open	15.32
Previous Close	15.30
Day's Range	14.98 - 15.62
52-Week Range	14.64 - 29.49
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Shanghai ZJ Bio-Tech

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 275
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688317

Financial Performance

In 2025, Shanghai ZJ Bio-Tech's revenue was 124.82 million, a decrease of -30.13% compared to the previous year's 178.65 million. Losses were -34.30 million, -73.09% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 22, 2026

Data Sources Report a data error